
Simon Chesterman; Oxford Business Law
Since computers entered into the mainstream in the
1960s, the efficiency with which data could be processed has raised regulatory
questions. This is well understood with respect to privacy. Data that was
notionally public—divorce proceedings, say—had long been protected through the
‘practical obscurity’ of paper records. When such material was available in a
single hard copy in a government office, the chances of one’s acquaintances or
employer finding it was remote. Yet when it was computerized and made
searchable through what ultimately became the Internet, such practical obscurity
disappeared.
Today, high-speed computing poses comparable
challenges to existing regulatory models in areas from securities regulation to
competition law, merely by enabling lawful activities—trading in stocks, or
comparing and adjusting prices, say—to be undertaken more quickly than
previously conceived possible. Many of these questions are practical rather
than conceptual. Nevertheless, current approaches to slowing down such
decision-making—through circuit-breakers to slow or stop trading, for example—are
unlikely to address all of the problems raised by the speed of AI systems
currently in use.
My article considers the regulatory challenges posed by speed. Many of the transformations in the digital economy—breathlessly referred to as the ‘fourth industrial revolution’—are more accurately linked to the speed and efficiency of data processing rather than true cognitive ability or ‘intelligence’ as such…
Featured News
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
EU and UK Finalize Deal to Strengthen Antitrust Cooperation
May 20, 2025 by
CPI
Clemens Food Group Reaches $13.5 Million Settlement in Pork Price-Fixing Suit
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas